Cannabidiol for people with schizophrenia

Diana Buitrago-Garcia; Guillermo Sánchez Vanegas; Paula Alejandra Sánchez Correa; Stela del pilar Baracaldo; Santiago Felipe Gallego Gallego; Lone Baandrup

doi:10.1002/14651858.CD014602

Cannabidiol for people with schizophrenia

Diana Buitrago-Garcia^*, Guillermo Sánchez Vanegas, Paula Alejandra Sánchez Correa, Stela del pilar Baracaldo, Santiago Felipe Gallego Gallego, Lone Baandrup

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of CBD in the treatment of people with schizophrenia.

Original language	English
Article number	CD014602
Journal	Cochrane Database of Systematic Reviews
Volume	2022
Issue number	11
ISSN	1465-1858
DOIs	https://doi.org/10.1002/14651858.CD014602
Publication status	Published - 2022

Bibliographical note

Publisher Copyright:
Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Access to Document

10.1002/14651858.CD014602

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667351/pdf/CD014602.pdfLicence: Other

Library access?

Check availability at the Royal Danish Library

Cite this

@article{02c5e13992f040cab967233573c8885f,

title = "Cannabidiol for people with schizophrenia",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of CBD in the treatment of people with schizophrenia.",

author = "Diana Buitrago-Garcia and {S{\'a}nchez Vanegas}, Guillermo and {S{\'a}nchez Correa}, {Paula Alejandra} and Baracaldo, {Stela del pilar} and {Gallego Gallego}, {Santiago Felipe} and Lone Baandrup",

note = "Publisher Copyright: Copyright {\textcopyright} 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2022",

doi = "10.1002/14651858.CD014602",

language = "English",

volume = "2022",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "Wiley",

number = "11",

}

TY - JOUR

T1 - Cannabidiol for people with schizophrenia

AU - Buitrago-Garcia, Diana

AU - Sánchez Vanegas, Guillermo

AU - Sánchez Correa, Paula Alejandra

AU - Baracaldo, Stela del pilar

AU - Gallego Gallego, Santiago Felipe

AU - Baandrup, Lone

PY - 2022

Y1 - 2022

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of CBD in the treatment of people with schizophrenia.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effectiveness and safety of CBD in the treatment of people with schizophrenia.

U2 - 10.1002/14651858.CD014602

DO - 10.1002/14651858.CD014602

M3 - Journal article

AN - SCOPUS:85142045544

SN - 1465-1858

VL - 2022

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 11

M1 - CD014602

ER -